Paper36958134
Staphylococcus aureus vaccine strategy: Promise and challenges.
Chand U and 2 others. Microbiol Res, 2023. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. Staphylococcus aureus vaccine strategy: Promise and challenges. Papers, record 36958134. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36958134
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Methicillin-Resistant Staphylococcus aureus | Major topic |
| Staphylococcal Infections | Major topic |
| Staphylococcal Vaccines | Major topic |
| Humans | |
| Staphylococcus aureus | |
| Vaccine Development |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42920946 | WHO Bacterial Priority Pathogens List: a 32-year global trend and inequality analysis of antimicrobial resistance burden by age and region. | BMJ Public Health | 2026 | https://conductscience.org/library/papers/42920946 | PubMed |
| 42599583 | Immunization with PLGA-encapsulated recombinant staphylococcal enterotoxin C confers protection against intramammary Staphylococcus aureus challenge in a murine mastitis model. | Antonie Van Leeuwenhoek | 2026 | https://conductscience.org/library/papers/42599583 | PubMed |
| 42476979 | High-throughput antigen discovery using Functional Genomic Vaccinology (FGV) identifies protective Streptococcus pneumoniae vaccine candidates. | Nat Commun | 2026 | https://conductscience.org/library/papers/42476979 | PubMed |
| 42267312 | PLGA-PEG Nano-Adjuvant-Delivered ClfA Vaccine Elicits IL-17A-Mediated Neutrophil Activation to Confer Complete Protection Against Methicillin-Resistant Staphylococcus aureus. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42267312 | PubMed |
| 41945621 | Computational and immunoinformatics approaches for designing phytocompound-based drugs and a multi-epitope vaccine targeting FemA, a cell wall protein of Staphylococcus aureus. | PLoS One | 2026 | https://conductscience.org/library/papers/41945621 | PubMed |
| 41754453 | Managing Bone Infections Beyond Systemic Antibiotics: A Scoping Review. | Pathogens | 2026 | https://conductscience.org/library/papers/41754453 | PubMed |
| 41746089 | Rational Combination of Dominant and Subdominant Antigens with Nanoadjuvant Elicits Durable Immunity Against Staphylococcus aureus. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41746089 | PubMed |
| 41599011 | Taming Superbugs: Current Progress and Challenges in Combating ESKAPE Pathogens. | Pathogens | 2025 | https://conductscience.org/library/papers/41599011 | PubMed |
| 41258067 | Clinical characteristics of Torquetenovirus infected immunocompromised patients explored by metagenomic next-generation sequencing. | Sci Rep | 2025 | https://conductscience.org/library/papers/41258067 | PubMed |
| 41256845 | Synergistic nano-vaccine strategy for comprehensive activation of adaptive and innate immunity against Staphylococcus aureus infection. | Front Immunol | 2025 | https://conductscience.org/library/papers/41256845 | PubMed |
| 41190079 | Integrated immunodominant epitope discovery for dual-purpose rapid and economical diagnostic and immunoprotective applications against MRSA. | Front Immunol | 2025 | https://conductscience.org/library/papers/41190079 | PubMed |
| 40939045 | Overcoming Immune Evasion in Staphylococcus aureus: Strategies for Rational Vaccine Design. | ACS Infect Dis | 2025 | https://conductscience.org/library/papers/40939045 | PubMed |
| 40865524 | Uncovering phenotypic inheritance from single cells with Microcolony-seq. | Cell | 2025 | https://conductscience.org/library/papers/40865524 | PubMed |
| 40657165 | Viral Etiologies of Acute Respiratory Illness in Older Adults and of Congestive Heart Failure and Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization During 2 Prepandemic Respiratory Seasons. | Open Forum Infect Dis | 2025 | https://conductscience.org/library/papers/40657165 | PubMed |
| 40563867 | Immunogenicity Evaluation of Epitope-Based Vaccine on Target of RNAIII-Activating Protein (TRAP) of Staphylococcus Aureus. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/40563867 | PubMed |
| 40426537 | Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/40426537 | PubMed |
| 40116634 | Surface display of LukF-PV on Bacillus subtilis spore for oral administration. | Future Microbiol | 2025 | https://conductscience.org/library/papers/40116634 | PubMed |
| 40005560 | Staphylococcus aureus in Inflammation and Pain: Update on Pathologic Mechanisms. | Pathogens | 2025 | https://conductscience.org/library/papers/40005560 | PubMed |
| 39911705 | Global insights into MRSA bacteremia: a bibliometric analysis and future outlook. | Front Microbiol | 2024 | https://conductscience.org/library/papers/39911705 | PubMed |
| 39596740 | Potential Therapeutic Targets for Combination Antibody Therapy Against Staphylococcus aureus Infections. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39596740 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36958134
GET https://conductscience.org/api/papers/v1/36958134/cited_by?page=2